Supply Chain Archives

04/22/2025
Advancing Standardization in Cell and Gene Therapy Supply Chains
The future of cell and gene therapy depends not only on scientific advancements but also on the efficiency and reliability of its supply chain. In a recent panel discussion at Advanced Therapies Congress in London, Mark Flower, VP of Business Development, Cryopreservation at Cryoport Systems, explored the critical need for standardization, the challenges in achieving it, and the opportunities to improve logistics, manufacturing, and delivery systems.
04/18/2025
Transforming Patient Access to CGT: Q&A with Aruna Mor
Aruna Mor, Chief Commercial Officer at Cryoport Systems, recently delivered a powerful keynote at Advanced Therapies Congress in London, shedding light on the complexities of patient access and the critical steps needed to overcome these barriers. We sat down with her to delve deeper into some of the key themes of her keynote, exploring the intersection of science, logistics, supply chain, regulation, and collaboration that will determine the future of Cell and Gene Therapy (CGT).
03/04/2025
How Our Recent Innovative Solutions Meet Today’s Supply Chain Challenges
When advanced therapy organizations place innovation at the center of their approach to solving supply chain challenges, they prioritize the most important person involved – the waiting patient. An innovative, patient-centric approach reframes obstacles to focus on solutions that can ensure the vitality and protection of sensitive materials throughout every stage and phase of the journey to the patient’s bedside.
02/04/2025
World Cancer Day: Advancing the Fight with Cell and Gene Therapies
Each year on World Cancer Day, the global community comes together to raise awareness, encourage prevention, and support those affected by cancer. It is a day of reflection, a time to recognize the immense progress that has been made in cancer research while acknowledging the work that still lies ahead.
01/23/2025
Cryoport Systems Awarded the Simon Ellisson Supply Chain Innovation Award at Advanced Therapies Awards 2025
Cryoport Systems is proud to announce that we were awarded the prestigious Simon Ellison Supply Chain Innovation Award last night at Advanced Therapies Awards 2025.
01/06/2025
The Future of Gene Therapy Logistics – A Pivotal Moment
Gene therapy is set to transform healthcare, but its success depends on logistics systems that can adapt and scale in line with the industry’s growth. Cryoport Systems is proud to support this exciting frontier with logistics solutions that prioritize product integrity, security, and compliance.
12/23/2024
Meeting Market Needs through Collaboration and Customization
At Cryoport Systems, we understand that meaningful innovation comes not only from advanced technology but also from deeply collaborative relationships with our clients. Our collaborative approach has driven development of next-generation shipping systems and supply chain solutions, leaning on real-world insights from our clients to shape features, functionality, and future advancements.
10/04/2024
Certify Safety for Human-derived Materials with Advanced Therapy Shippers®
The risk of contamination can compromise life-saving therapies, making it a major concern within the world of transporting precision medicines.
09/03/2024
Cryoshuttle® Service Brings Local Support to Stevenage, England
In June, Cryoport Systems officially launched our newest Global Supply Chain Hub in Stevenage, England, a renowned center for cell and gene therapy development within the U.K.
08/26/2024
3 Fundamental Services for Superior Master Cell Bank Management
The consistency of controlled conditions is vital throughout every step in producing advanced therapies, and the process usually begins with the secure handling and storage of the cells used for manufacturing.Categories
- All (57)
- Industry Insights (16)
- Managing the Cold Chain (16)
- Navigating Logistics (21)
- Patient Access and Awareness (4)